Skip to main content Accessibility help
×
Home
Hostname: page-component-55597f9d44-vkn6t Total loading time: 0.243 Render date: 2022-08-19T02:18:09.936Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true } hasContentIssue true

Long-term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life evaluation

Published online by Cambridge University Press:  03 September 2014

I Dallan
Affiliation:
First ENT Unit, University of Pisa, Italy
S Fortunato*
Affiliation:
First ENT Unit, University of Pisa, Italy
A P Casani
Affiliation:
First ENT Unit, University of Pisa, Italy
E Bernardini
Affiliation:
First ENT Unit, University of Pisa, Italy
S Sellari-Franceschini
Affiliation:
First ENT Unit, University of Pisa, Italy
S Berrettini
Affiliation:
ENT Audiology Phoniatry Unit, Department of Neuroscience, University of Pisa, Italy
A Nacci
Affiliation:
ENT Audiology Phoniatry Unit, Department of Neuroscience, University of Pisa, Italy
*
Address for correspondence: Dr S Fortunato, First ENT Unit, Azienda Ospedaliero-Universitaria Pisana, Via Paradisa, 3, 56126 Pisa, Italy Fax: +39 (0)50 997517 E-mail: susanna.fortunato@gmail.com

Abstract

Objective:

To evaluate the long-term stability of intratympanic steroids and investigate the ‘real’ impact of sudden sensorineural hearing loss on patients.

Method:

A total of 14 patients treated with intratympanic steroids were evaluated by audiometric and vestibular examinations. The modified Glasgow Benefit Inventory was used to evaluate quality of life changes after intratympanic steroid treatment.

Results:

There was no significant difference between pure tone average post-intratympanic steroids and at follow up. The general Glasgow Benefit Inventory score was not significantly associated with the presence of tinnitus or dizziness, or with patient age. The change in pure tone average after intratympanic steroid treatment did not correlate with social or physical scores, but correlated strongly with the general Glasgow Benefit Inventory score (p = 0.0023). Intratympanic steroid administration led to a stable improvement in hearing. Quality of life assessment showed that patients can feel satisfaction regardless of the hearing outcome. Patients who regained a social hearing level expressed greater satisfaction than patients without serviceable hearing. Overall, quality of life improvement was not related to hearing improvement.

Conclusion:

Sudden sensorineural hearing loss is devastating. Considering the audiological effects alone ignores the ‘human’ perspective. Audiological success can correlate with poor quality of life outcome.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Hughes, GB, Freedman, MA, Haberkamp, TJ, Guay, ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996;29:393405Google ScholarPubMed
2Mattox, DE, Simmons, FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80CrossRefGoogle ScholarPubMed
3Rauch, SD, Halpin, CF, Antonelli, PJ, Babu, S, Carey, JP, Gantz, BJ et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305:2071–9CrossRefGoogle ScholarPubMed
4Robinson, K, Gatehouse, S, Browning, GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 2006;105:415–22CrossRefGoogle Scholar
5Kyrodimos, E, Aidonis, I, Skalimis, A, Sismanis, A. Use of Glasgow Benefit Inventory (GBI) in Meniere's disease managed with intratympanic dexamethasone perfusion: quality of life assessment. Auris Nasus Larynx 2011;38:172–7CrossRefGoogle ScholarPubMed
6Stachler, RJ, Chandrasekhar, SS, Archer, SM, Rosenfeld, RM, Schwartz, SR, Barrs, DM et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(suppl3):S1–35CrossRefGoogle ScholarPubMed
7Carlosson, PI, Hall, M, Lind, KJ, Danermark, B. Quality of life, psychosocial consequences, and audiological rehabilitation after sudden sensorineural hearing loss. Int J Audiol 2011;50:139–44CrossRefGoogle Scholar
8Yeo, SW, Lee, DH, Jun, BC, Park, SY, Park, YS. Hearing outcome of sudden sensorineural hearing loss: long-term follow up. Otolaryngol Head Neck Surg 2007;136:221–4CrossRefGoogle ScholarPubMed
9Vrabec, JT. Effectiveness of intratympanic dexamethasone injection in sudden deafness patients as salvage treatment. Laryngoscope 2005;115:378CrossRefGoogle ScholarPubMed
10Kallinen, J, Laurikainen, E, Bergroth, L, Grenman, R. A follow up study of patients suffering from sudden sensorineural hearing loss. Acta Otolaryngol 2001;121:818–22CrossRefGoogle ScholarPubMed
11Furuhashi, A, Matzuda, K, Asahi, K, Nakashima, T. Sudden deafness: long-term follow up and recurrences. Clin Otolaryngol 2002;27:458–63CrossRefGoogle Scholar
12Lin, HC, Chao, PZ, Lee, HC. Sudden sensorineural hearing loss increases the risk of stroke: a 5-year follow-up study. Stroke 2008;39:2744–8CrossRefGoogle ScholarPubMed
15
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Long-term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life evaluation
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Long-term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life evaluation
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Long-term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life evaluation
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *